Nerolen Soobryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nerolen Soobryan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Irene Mackraj
Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of Kwazulu-Natal, Durban, South Africa
4 shared publications Jagidesa Moodley
Department of Obstetrics and Gynaecology and Women's Health and HIV Research Unit, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
3 shared publicationsPrem Gathiram
Department of Family Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
2 shared publications- Saravanakumar Murugesan
Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
2 shared publications - Ajit Kumar
Discipline of Microbiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal (Westville Campus), Durban, Republic of South Africa
1 shared publication Arunagiri Pandiyan
Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
1 shared publication
Latest Publications
- 22 July 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (7) , 2698-2703
An observational study of pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry
Hypertensive disorders in pregnancy (HDPs) are the leading cause of maternal and perinatal deaths worldwide. Despite the widely reported multisystemic pathophysiology of pre-eclampsia and other HDPs, it is unknown whether these disorders represent a continuum or separate entities making clinical diagnosis a challenge. This study aimed to investigate angiogenic, metabolic and immunoregulatory specific profiles of hypertensive and gestationally matched normotensive pregnancies. A total of 200 pregnancies from a regional hospital in South Africa, via convenience sampling, were quantitatively analysed for circulating sFlt-1; PlGF; VEGF; sENG; PAPP-A; PP13; ADAMTS 12; TGF-β1 in maternal serum samples using ELISA technique. Serum protein markers TGF-β1, sENG and PAPP-A were significantly increased (p < .05) in early-onset pre-eclampsia vs. NG1 groups. sFlt-1 was significantly higher in late-onset pre-eclampsia vs NG2 groups. The GH group showed a significant increase in TGF-β1 and PAPP-A vs. NG1 counterpart. ADAMTS12 and sENG were significantly lower in gestational hypertension vs. early-onset pre-eclampsia. No significant differences were seen in PlGF, VEGF and PP13 levels across the groups. These changes show the HDP spectrum has distinct characteristics on the angiogenic profile. Based on these results, further validation of diagnostic and prognostic biomarkers of pre-eclampsia and gestational hypertension is warranted.
- 22 July 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (7) , 2698-2703
An observational study of pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry
Hypertensive disorders in pregnancy (HDPs) are the leading cause of maternal and perinatal deaths worldwide. Despite the widely reported multisystemic pathophysiology of pre-eclampsia and other HDPs, it is unknown whether these disorders represent a continuum or separate entities making clinical diagnosis a challenge. This study aimed to investigate angiogenic, metabolic and immunoregulatory specific profiles of hypertensive and gestationally matched normotensive pregnancies. A total of 200 pregnancies from a regional hospital in South Africa, via convenience sampling, were quantitatively analysed for circulating sFlt-1; PlGF; VEGF; sENG; PAPP-A; PP13; ADAMTS 12; TGF-β1 in maternal serum samples using ELISA technique. Serum protein markers TGF-β1, sENG and PAPP-A were significantly increased (p < .05) in early-onset pre-eclampsia vs. NG1 groups. sFlt-1 was significantly higher in late-onset pre-eclampsia vs NG2 groups. The GH group showed a significant increase in TGF-β1 and PAPP-A vs. NG1 counterpart. ADAMTS12 and sENG were significantly lower in gestational hypertension vs. early-onset pre-eclampsia. No significant differences were seen in PlGF, VEGF and PP13 levels across the groups. These changes show the HDP spectrum has distinct characteristics on the angiogenic profile. Based on these results, further validation of diagnostic and prognostic biomarkers of pre-eclampsia and gestational hypertension is warranted.
- 1 November 2018
- Published by Springer Nature in Reproductive Sciences
- Vol. 25 (11) , 1531-1539
Angiogenic Dysregulation in Pregnancy-Related Hypertension—A Role for Metformin
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.
- 1 November 2018
- Published by Springer Nature in Reproductive Sciences
- Vol. 25 (11) , 1531-1539
Angiogenic Dysregulation in Pregnancy-Related Hypertension—A Role for Metformin
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.
- 1 January 2017
- Published by Elsevier in European Journal of Pharmacology
- Vol. 795, 101-107
The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia
- 1 January 2017
- Published by Elsevier in European Journal of Pharmacology
- Vol. 795, 101-107
The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia